Skip to main content
. 2017 Aug 16;5(1):15–30. doi: 10.1016/j.jcmgh.2017.08.001

Figure 3.

Figure 3

(A) Kaplan-Meier analyses representing the percent survival of irradiated HIF-1αFL/FLand HIF-1αFL/FLVillinCre+/-mice after 19 -Gy localized intestinal radiation exposure. (B) Representative microscopic alterations obtained in HIF-1αFL/FL and in HIF-1αFL/FLVillin-Cre+/- mice 3 and 7 days after irradiation. Slides were stained with hematoxylin-eosin-saffron. Scale bar = 100 μm. (C) Radiation injury score in HIF-1αFL/FL and in HIF-1αFL/FLVillin-Cre+/- mice 3 and 7 days after irradiation (n = 8–10 mice per group). (D) Radiation injury score in HIF-1αFL/FL and in HIF-1αFL/FLVillin-CreERt2+/- mice treated with tamoxifen 3 and 7 days after irradiation (n = 6–8 mice per group). (E) Kaplan-Meier analyses representing the percent survival of irradiated HIF-1αFL/FL and HIF-1αFL/FLVillinCre+/- mice after 13-Gy total body irradiation (NS, P = .0513). NS, not significant.